Skyrizi

Skyrizi Warnings and Precautions

• Hypersensitivity reactions: Serious reactions, including anaphylaxis, have been reported. Skyrizi is contraindicated in patients with a history of serious hypersensitivity to risankizumab-rzaa or its excipients.
• Increased risk of infection: Skyrizi may increase susceptibility to infections; patients should be evaluated for tuberculosis before starting treatment.
• Liver toxicity: Liver enzyme monitoring is recommended, particularly when Skyrizi is used for inflammatory bowel disease.
• Vaccinations: Live vaccines should be avoided during treatment; patients should be up to date on vaccinations before starting.

How to Access Skyrizi in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant, cold-chain conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Skyrizi to India?

Skyrizi (risankizumab-rzaa) injection may be imported in the patient's name only, by patients or government hospitals, in line with India's import regulations for unapproved medicines. The following documentation is required:

• A valid prescription from a qualified dermatologist, rheumatologist, or gastroenterologist
• The patient's diagnostic reports confirming the relevant condition (plaque psoriasis, psoriatic arthritis, Crohn's disease, or ulcerative colitis)
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.

Is Skyrizi available in India?

Skyrizi (risankizumab-rzaa injection) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Skyrizi is not commercially marketed in India.

However, patients in India can legally access Skyrizi through the Named Patient Program (NPP) — an import provision that allows patients to receive medicines approved in other countries but not yet marketed in India, under a doctor's prescription and proper regulatory documentation.

Skyrizi received US FDA approval for moderate-to-severe plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis, ensuring full transparency throughout the process.

Skyrizi can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others.

For patients with plaque psoriasis or psoriatic arthritis, NPP also facilitates access to Bimzelx, another biologic option, based on the treating dermatologist's or rheumatologist's assessment.

For patients with Crohn's disease or ulcerative colitis, NPP also facilitates access to Entyvio, another biologic option, based on the treating gastroenterologist's assessment.

Sourcing & Delivery of Skyrizi

Skyrizi is sourced directly from authorized channels in the country of origin and shipped to India under GDP-compliant, cold-chain logistics to preserve product integrity from dispatch to delivery.

• Cold-chain shipping maintained at 2°C to 8°C throughout transit
• Real-time shipment tracking and delivery updates
• Delivery coordinated directly with the patient, family, or treating hospital

Availability of Skyrizi Across Major Cities in India

Named Patient Program supports access to Skyrizi for patients with plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis across major cities in India, coordinating documentation, sourcing, and delivery with treating specialists.

Mumbai

Patients in Mumbai can access Skyrizi through NPP with support from treating dermatologists, rheumatologists, and gastroenterologists at the city's leading centers.

Delhi

In Delhi, NPP coordinates with hospitals and specialty clinics to facilitate timely access to Skyrizi.

Bangalore

Bangalore's dermatology and gastroenterology centers work with NPP to support patients requiring Skyrizi.

Chennai

Patients in Chennai can access Skyrizi through NPP, with coordination between treating doctors and the program's regulatory and logistics team.

Hyderabad

Hyderabad's specialty immunology and gastroenterology centers support diagnosis and access coordination for Skyrizi through NPP.

Kolkata

NPP facilitates access to Skyrizi for patients in Kolkata under the guidance of treating specialists.

Pune

Patients in Pune can access Skyrizi through NPP with prescription-based coordination and cold-chain delivery support.

Ahmedabad

NPP supports access to Skyrizi for patients in Ahmedabad, working directly with treating specialists.

Kochi

Patients in Kochi and across Kerala can access Skyrizi through NPP's regulated import pathway.

Chandigarh

NPP coordinates access to Skyrizi for patients in Chandigarh and the surrounding region.

Jaipur

Patients in Jaipur can access Skyrizi through NPP with support from treating specialists.

Lucknow

NPP facilitates access to Skyrizi for patients in Lucknow and across Uttar Pradesh.

Bhubaneswar

Patients in Bhubaneswar can access Skyrizi through NPP's coordinated import and delivery process.

Guwahati

NPP supports access to Skyrizi for patients in Guwahati and across the Northeast region.

NPP also supports access for patients in other Indian cities not listed above — contact the team to check availability and timelines for your location.